findmyKOL
Clinical trialNCT01028508CompletedPhase 4Interventional

Prolonging Remission in Depressed Elderly (PRIDE)

SponsorIcahn School of Medicine at Mount SinaiEnrollment247Depression
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study will determine whether medications alone or medications and electroconvulsive therapy (ECT) work best to prevent depressive relapse and to improve quality of life for older people with severe mood disorders.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Georgia Regents University

    Augusta, Georgia, United States

  • Mayo Clinic

    Rochester, Minnesota, United States

  • Hoboken University Medical Center (mssm Satellite Site)

    Hoboken, New Jersey, United States

  • the Zucker Hillside Hospital North Shore-Lij Health System

    Glen Oaks, New York, United States

  • Columbia University/new York State Psychiatric Institute

    New York, New York, United States

  • Icahn School of Medicine at Mount Sinai

    New York, New York, United States

  • Weill Cornell Medical College

    White Plains, New York, United States

  • Duke University

    Durham, North Carolina, United States

  • Wake Forest University Medical Center

    Winston-Salem, North Carolina, United States

  • University of Texas Southwestern Medical Center at Dallas

    Dallas, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Lithium and Venlafaxine
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jan 2010
Primary completion
30 Sept 2015
Completion
31 Mar 2016
Last update posted
11 Apr 2017
Registered enrollment
247
Registry id
NCT01028508
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.